Publication | Closed Access
Motor Progression and Nigrostriatal Neurodegeneration in Parkinson Disease
35
Citations
40
References
2022
Year
We propose striatal dopaminergic terminal loss measured using <sup>123</sup> I-ioflupane SPECT and nigral dopamine neuron loss assessed with NM-MRI as early stage and advanced stage motor impairment biomarkers, respectively. ANN NEUROL 2022;92:110-121.
| Year | Citations | |
|---|---|---|
Page 1
Page 1